# Penumbra Inc

Summary updated: 2026-10-02T12:46:46.376454Z
Canonical: https://finbar.com/research/companies/penumbra-inc

## Overview

Penumbra, Inc. is a medical-technology company that develops, manufactures and markets devices for complex medical conditions. Its core business is thrombectomy—the removal of blood clots—with products used in neurovascular and peripheral vascular care, including treatment of ischemic stroke, pulmonary embolism and acute limb ischemia. Its portfolio also includes embolization, vascular-access and neurosurgical devices. [1](https://app.finbar.com/go?id=P145049282)[2](https://app.finbar.com/go?id=P145049285)[3](https://app.finbar.com/go?id=P145049288)[4](https://app.finbar.com/go?id=P145049298)

Penumbra’s products are used in more than 100 countries. Its stated mission is to innovate technologies that help as many people as possible. [5](https://app.finbar.com/go?id=P145049297)[6](https://www.penumbrainc.com/)

Founded in 2004, Penumbra reported FY2025 revenue of $1.404 billion and approximately 4,700 employees as of December 31, 2025. [7](https://app.finbar.com/go?id=P145049284)[8](https://app.finbar.com/go?id=T12848137)[9](https://www.sec.gov/ix?doc=%2FArchives%2Fedgar%2Fdata%2F0001321732%2F000132173226000007%2Fpen-20251231.htm)
[1](https://app.finbar.com/go?id=P145049282)[2](https://app.finbar.com/go?id=P145049285)[3](https://app.finbar.com/go?id=P145049288)[4](https://app.finbar.com/go?id=P145049298)[5](https://app.finbar.com/go?id=P145049297)[6](https://www.penumbrainc.com/)[7](https://app.finbar.com/go?id=P145049284)[8](https://app.finbar.com/go?id=T12848137)[9](https://www.sec.gov/ix?doc=%2FArchives%2Fedgar%2Fdata%2F0001321732%2F000132173226000007%2Fpen-20251231.htm)[6](https://www.penumbrainc.com/)[9](https://www.sec.gov/ix?doc=%2FArchives%2Fedgar%2Fdata%2F0001321732%2F000132173226000007%2Fpen-20251231.htm)

## Products & services

Penumbra’s neurovascular products include the Penumbra System, an aspiration-based mechanical thrombectomy system comprising reperfusion catheters, separators, a 3D Revascularization Device, tubing and an aspiration pump for removing clots from intracranial vessels. Its RED, JET, ACE, BMX and MAX catheter families serve different vessel and occlusion needs; RED catheters are designed to navigate complex distal-vessel anatomy while delivering aspiration for acute ischemic stroke. [10](https://app.finbar.com/go?id=P47323278)[11](https://app.finbar.com/go?id=P60446627)[12](https://app.finbar.com/go?id=P2450587)

For peripheral thrombectomy, the Indigo system provides continuous or modulated aspiration across peripheral arterial, venous, pulmonary and coronary vessels. Its CAT catheters come in multiple sizes and lengths, while CAVT combines catheters with microprocessor-controlled pump algorithms, including for pulmonary embolism, and is designed to support clot removal while mitigating blood loss. Product variants include Lightning Flash 3.0, with updated clot-detection algorithms, enlarged tubing and automated backflush, and Lightning Bolt 12 and Bolt 6X with TraX, which use modulated aspiration. [13](https://app.finbar.com/go?id=P113907371)[14](https://app.finbar.com/go?id=P36303008)[15](https://app.finbar.com/go?id=P14288957)[16](https://app.finbar.com/go?id=P109013512)

Embolization products include detachable Ruby coils, Ruby LP for smaller and more distal vessels, Ruby XL for large vessels and high-flow settings, POD coils for rapid target-vessel occlusion, and Packing Coils for packing behind Ruby or POD devices. Neuro embolization offerings include Penumbra Coil 400, SMART COIL, SwiftPAC and SwiftSET, designed for applications including aneurysm packing, progressive coil softness, dense packing and small-vessel occlusion. Other products include Neuron and BENCHMARK BMX guide catheters, MIDWAY delivery catheters, and the Artemis Neuro Evacuation Device, a minimally invasive system for removing fluid and tissue from the ventricles and cerebrum. [17](https://app.finbar.com/go?id=P97290266)[18](https://app.finbar.com/go?id=P50100864)[19](https://app.finbar.com/go?id=P88230607)[20](https://app.finbar.com/go?id=P21089966)[21](https://app.finbar.com/go?id=P78522340)[22](https://app.finbar.com/go?id=P112826492)[23](https://app.finbar.com/go?id=P92497135)[24](https://app.finbar.com/go?id=P69618692)[25](https://app.finbar.com/go?id=P90243338)[26](https://app.finbar.com/go?id=P16434335)[27](https://app.finbar.com/go?id=P38359972)[28](https://app.finbar.com/go?id=P267195)

The company’s 2025 product-offerings summary also lists brands including CAT RX, SENDit, LANTERN, POD400, PAC400, Neuron MAX, DDC, PX SLIM and Access25. The reviewed 2025 annual and Q2 2026 reports do not disclose revenue percentages by named product or product family. [29](https://app.finbar.com/go?id=T2635974)[30](https://app.finbar.com/go?id=P145049338)
[10](https://app.finbar.com/go?id=P47323278)[11](https://app.finbar.com/go?id=P60446627)[12](https://app.finbar.com/go?id=P2450587)[13](https://app.finbar.com/go?id=P113907371)[14](https://app.finbar.com/go?id=P36303008)[15](https://app.finbar.com/go?id=P14288957)[16](https://app.finbar.com/go?id=P109013512)[17](https://app.finbar.com/go?id=P97290266)[18](https://app.finbar.com/go?id=P50100864)[19](https://app.finbar.com/go?id=P88230607)[20](https://app.finbar.com/go?id=P21089966)[21](https://app.finbar.com/go?id=P78522340)[22](https://app.finbar.com/go?id=P112826492)[23](https://app.finbar.com/go?id=P92497135)[24](https://app.finbar.com/go?id=P69618692)[25](https://app.finbar.com/go?id=P90243338)[26](https://app.finbar.com/go?id=P16434335)[27](https://app.finbar.com/go?id=P38359972)[28](https://app.finbar.com/go?id=P267195)[29](https://app.finbar.com/go?id=T2635974)[30](https://app.finbar.com/go?id=P145049338)

## Geographic presence

In FY2025, Penumbra reported 77.8% of revenue from the United States and 22.2% from international markets; it did not provide a country-by-country revenue split in the cited disclosure. [31](https://www.penumbrainc.com/penumbra-inc-reports-fourth-quarter-and-full-year-2025-financial-results/) The company has direct sales capability in the U.S., most of Europe, Canada, Australia and Singapore, and uses distributors in other international markets. Distributor sales accounted for 10.0% of 2025 revenue. [32](https://app.finbar.com/go?id=P13461068)

Penumbra identifies its global headquarters in Alameda, California. [33](https://www.penumbrainc.com/contact-us/) It produces substantially all products in-house at facilities in Alameda and Roseville, California; as of December 31, 2025, it also reported warehouse space in Livermore, California, and Salt Lake City, Utah. [34](https://app.finbar.com/go?id=P105341837)[35](https://app.finbar.com/go?id=P1184232) The company disclosed plans for a manufacturing facility and warehouse in Costa Rica, with operations expected to begin in 2027. [36](https://app.finbar.com/go?id=P40821933)[37](https://www.procomer.com/penumbra-inc-elige-a-costa-rica-para-instalar-su-nueva-planta-de-manufactura/)
[32](https://app.finbar.com/go?id=P13461068)[34](https://app.finbar.com/go?id=P105341837)[35](https://app.finbar.com/go?id=P1184232)[36](https://app.finbar.com/go?id=P40821933)[31](https://www.penumbrainc.com/penumbra-inc-reports-fourth-quarter-and-full-year-2025-financial-results/)[33](https://www.penumbrainc.com/contact-us/)[38](https://www.procomer.com/penumbra-inc-elige-a-costa-rica-para-instalar-a-su-nueva-planta-de-manufactura/)

## Business segments

Penumbra reports one operating and reportable segment, encompassing the design, development, manufacture and marketing of its medical products. Its product-category revenue disclosures are a disaggregation of revenue, not separately reported operating segments. [39](https://app.finbar.com/go?id=P145049107)[40](https://app.finbar.com/go?id=P145049246)

The company disaggregates revenue into **Thrombectomy** and **Embolization and access**. Thrombectomy includes neurovascular and peripheral thrombectomy products; it generated approximately $947.9 million, or 67.5% of 2025 revenue. Embolization and access includes embolization products, vascular access catheters and neurosurgical tools; it generated approximately $455.7 million, or 32.5% of 2025 revenue. [41](https://app.finbar.com/go?id=P40075394)[29](https://app.finbar.com/go?id=T2635974)[8](https://app.finbar.com/go?id=T12848137)
[39](https://app.finbar.com/go?id=P145049107)[40](https://app.finbar.com/go?id=P145049246)[41](https://app.finbar.com/go?id=P40075394)[29](https://app.finbar.com/go?id=T2635974)[8](https://app.finbar.com/go?id=T12848137)

## Company history

Penumbra was founded in Alameda, California, in 2004 by Adam Elsesser and Dr. Arani Bose. It entered the neurovascular market with its first product in 2007, followed by the U.S. launch of the Penumbra System in 2008. The company expanded into embolization in 2011, peripheral vascular products in 2013, and neurosurgical products in 2014; the Indigo System was also introduced in 2014. [42](https://app.finbar.com/go?id=P19779401)[43](https://app.finbar.com/go?id=P191213424)[44](https://app.finbar.com/go?id=P191212783)

Penumbra became a public company in 2015, with its shares beginning to trade on the New York Stock Exchange under the symbol PEN in September. In 2018, it formed MVI Health, a virtual-reality healthcare venture with Sixense, and later that year acquired a controlling interest in the venture. [45](https://app.finbar.com/go?id=P191213397)[46](https://www.penumbrainc.com/penumbra-announces-the-formation-of-joint-venture-mvi-health/)[47](https://www.penumbrainc.com/penumbra-inc-announces-acquisition-of-controlling-interest-in-mvi-health/)

Leadership changes followed in 2019–20: Sri Kosaraju became president in 2019, and Elsesser returned to the presidency in 2020 while continuing as CEO. In subsequent years, Penumbra introduced new thrombectomy technologies, including Lightning Flash in 2023, and expanded its commercial reach through European product launches and a partnership aimed at introducing the Indigo System in Japan. [48](https://www.penumbrainc.com/sri-kosaraju-promoted-to-president-and-cfo-of-penumbra/)[49](https://www.penumbrainc.com/penumbra-announces-management-transition/)[50](https://www.penumbrainc.com/penumbra-launches-latest-innovation-in-mechanical-thrombectomy-lightning-flash/)[51](https://www.penumbrainc.com/penumbra-announces-european-launch-of-red-reperfusion-catheters-for-stroke-care/)[52](https://www.penumbrainc.com/penumbra-and-asahi-intecc-partner-with-goal-of-introducing-indigo-system-including-lightning-intelligent-aspiration-to-japan/)
[42](https://app.finbar.com/go?id=P19779401)[43](https://app.finbar.com/go?id=P191213424)[44](https://app.finbar.com/go?id=P191212783)[45](https://app.finbar.com/go?id=P191213397)[46](https://www.penumbrainc.com/penumbra-announces-the-formation-of-joint-venture-mvi-health/)[47](https://www.penumbrainc.com/penumbra-inc-announces-acquisition-of-controlling-interest-in-mvi-health/)[48](https://www.penumbrainc.com/sri-kosaraju-promoted-to-president-and-cfo-of-penumbra/)[49](https://www.penumbrainc.com/penumbra-announces-management-transition/)[50](https://www.penumbrainc.com/penumbra-launches-latest-innovation-in-mechanical-thrombectomy-lightning-flash/)[51](https://www.penumbrainc.com/penumbra-announces-european-launch-of-red-reperfusion-catheters-for-stroke-care/)[52](https://www.penumbrainc.com/penumbra-and-asahi-intecc-partner-with-goal-of-introducing-indigo-system-including-lightning-intelligent-aspiration-to-japan/)

## Sources

1. [Penumbra Inc — Full financial report (2026 Q 2)](https://app.finbar.com/go?id=P145049282)
2. [Penumbra Inc — Full financial report (2026 Q 2)](https://app.finbar.com/go?id=P145049285)
3. [Penumbra Inc — Full financial report (2026 Q 2)](https://app.finbar.com/go?id=P145049288)
4. [Penumbra Inc — Full financial report (2026 Q 2)](https://app.finbar.com/go?id=P145049298)
5. [Penumbra Inc — Full financial report (2026 Q 2)](https://app.finbar.com/go?id=P145049297)
6. [www.penumbrainc.com](https://www.penumbrainc.com/)
7. [Penumbra Inc — Full financial report (2026 Q 2)](https://app.finbar.com/go?id=P145049284)
8. [Penumbra Inc — Full financial report (2025 Y)](https://app.finbar.com/go?id=T12848137)
9. [www.sec.gov](https://www.sec.gov/ix?doc=%2FArchives%2Fedgar%2Fdata%2F0001321732%2F000132173226000007%2Fpen-20251231.htm)
10. [Penumbra Inc — Full financial report (2025 Y)](https://app.finbar.com/go?id=P47323278)
11. [Penumbra Inc — Full financial report (2025 Y)](https://app.finbar.com/go?id=P60446627)
12. [Penumbra Inc — Full financial report (2025 Y)](https://app.finbar.com/go?id=P2450587)
13. [Penumbra Inc — Full financial report (2025 Y)](https://app.finbar.com/go?id=P113907371)
14. [Penumbra Inc — Full financial report (2025 Y)](https://app.finbar.com/go?id=P36303008)
15. [Penumbra Inc — Full financial report (2025 Y)](https://app.finbar.com/go?id=P14288957)
16. [Penumbra Inc — Full financial report (2025 Y)](https://app.finbar.com/go?id=P109013512)
17. [Penumbra Inc — Full financial report (2025 Y)](https://app.finbar.com/go?id=P97290266)
18. [Penumbra Inc — Full financial report (2025 Y)](https://app.finbar.com/go?id=P50100864)
19. [Penumbra Inc — Full financial report (2025 Y)](https://app.finbar.com/go?id=P88230607)
20. [Penumbra Inc — Full financial report (2025 Y)](https://app.finbar.com/go?id=P21089966)
21. [Penumbra Inc — Full financial report (2025 Y)](https://app.finbar.com/go?id=P78522340)
22. [Penumbra Inc — Full financial report (2025 Y)](https://app.finbar.com/go?id=P112826492)
23. [Penumbra Inc — Full financial report (2025 Y)](https://app.finbar.com/go?id=P92497135)
24. [Penumbra Inc — Full financial report (2025 Y)](https://app.finbar.com/go?id=P69618692)
25. [Penumbra Inc — Full financial report (2025 Y)](https://app.finbar.com/go?id=P90243338)
26. [Penumbra Inc — Full financial report (2025 Y)](https://app.finbar.com/go?id=P16434335)
27. [Penumbra Inc — Full financial report (2025 Y)](https://app.finbar.com/go?id=P38359972)
28. [Penumbra Inc — Full financial report (2025 Y)](https://app.finbar.com/go?id=P267195)
29. [Penumbra Inc — Full financial report (2025 Y)](https://app.finbar.com/go?id=T2635974)
30. [Penumbra Inc — Full financial report (2026 Q 2)](https://app.finbar.com/go?id=P145049338)
31. [www.penumbrainc.com](https://www.penumbrainc.com/penumbra-inc-reports-fourth-quarter-and-full-year-2025-financial-results/)
32. [Penumbra Inc — Full financial report (2025 Y)](https://app.finbar.com/go?id=P13461068)
33. [www.penumbrainc.com](https://www.penumbrainc.com/contact-us/)
34. [Penumbra Inc — Full financial report (2025 Y)](https://app.finbar.com/go?id=P105341837)
35. [Penumbra Inc — Full financial report (2025 Y)](https://app.finbar.com/go?id=P1184232)
36. [Penumbra Inc — Full financial report (2025 Y)](https://app.finbar.com/go?id=P40821933)
37. [www.procomer.com](https://www.procomer.com/penumbra-inc-elige-a-costa-rica-para-instalar-su-nueva-planta-de-manufactura/)
38. [www.procomer.com](https://www.procomer.com/penumbra-inc-elige-a-costa-rica-para-instalar-a-su-nueva-planta-de-manufactura/)
39. [Penumbra Inc — Full financial report (2026 Q 2)](https://app.finbar.com/go?id=P145049107)
40. [Penumbra Inc — Full financial report (2026 Q 2)](https://app.finbar.com/go?id=P145049246)
41. [Penumbra Inc — Full financial report (2025 Y)](https://app.finbar.com/go?id=P40075394)
42. [Penumbra Inc — Full financial report (2025 Y)](https://app.finbar.com/go?id=P19779401)
43. [Penumbra Inc — Full financial report (2015 Y)](https://app.finbar.com/go?id=P191213424)
44. [Penumbra Inc — Full financial report (2015 Y)](https://app.finbar.com/go?id=P191212783)
45. [Penumbra Inc — Full financial report (2015 Y)](https://app.finbar.com/go?id=P191213397)
46. [www.penumbrainc.com](https://www.penumbrainc.com/penumbra-announces-the-formation-of-joint-venture-mvi-health/)
47. [www.penumbrainc.com](https://www.penumbrainc.com/penumbra-inc-announces-acquisition-of-controlling-interest-in-mvi-health/)
48. [www.penumbrainc.com](https://www.penumbrainc.com/sri-kosaraju-promoted-to-president-and-cfo-of-penumbra/)
49. [www.penumbrainc.com](https://www.penumbrainc.com/penumbra-announces-management-transition/)
50. [www.penumbrainc.com](https://www.penumbrainc.com/penumbra-launches-latest-innovation-in-mechanical-thrombectomy-lightning-flash/)
51. [www.penumbrainc.com](https://www.penumbrainc.com/penumbra-announces-european-launch-of-red-reperfusion-catheters-for-stroke-care/)
52. [www.penumbrainc.com](https://www.penumbrainc.com/penumbra-and-asahi-intecc-partner-with-goal-of-introducing-indigo-system-including-lightning-intelligent-aspiration-to-japan/)

AI-generated summary; may contain errors. Not investment advice. Sign up to Finbar to view original document sources and access worldwide fundamental financial data and intelligence.